Measles: the United States, Mexico and Bolivia lose their measles elimination status
On 17 November 2026 the Pan American Health Organization (PAHO, the WHO regional office for the Americas) announced that endemic measles transmission has been re-established in the United States, Mexico and Bolivia. All three countries therefore lose their measles “elimination” status; for the United States, this is the first time since it was achieved in 2000.
Background: what “elimination” means
A country has eliminated measles when the virus no longer circulates on its own within its borders: imported cases and small outbreaks can still occur, but chains of transmission die out quickly. Keeping this status requires very high population immunity, because measles is one of the most contagious diseases known: one infected person can pass it on to as many as 18 unprotected people.
The Americas were the first region in the world to eliminate measles. The region lost its status in November 2025 because of sustained transmission in Canada, which has since interrupted the chain of transmission linked to that outbreak.
The news: the Commission’s decision
• The regional Commission that verifies measles and rubella elimination met from 10 to 13 November 2026
• The criterion: transmission is considered endemic again when the same genotype and lineage of the virus circulate without interruption for at least 12 months
• PAHO Director Jarbas Barbosa accepted the Commission’s recommendations for Bolivia, Mexico and the United States
• To regain the status, each country must submit a corrective action plan and show that transmission has been interrupted for at least 12 consecutive months
The figures
• From the start of 2026 to 13 November, the Americas confirmed 58,213 measles cases and 82 deaths
• In the same period of 2025 there were 12,806 cases: more than a fourfold increase
• The United States has reported over 5,400 cases in 2026, the highest number in decades
• Childhood coverage with the measles-mumps-rubella vaccine in the United States has fallen to around 92%, below the 95% threshold needed for herd immunity
The role of the laboratory
Behind PAHO’s decision lies, above all, laboratory work. Showing that “the same virus” has been circulating for more than a year takes more than counting cases: each case must be confirmed and traced back to its strain.
• Measles IgM antibodies in blood: confirm a recent infection, usually a few days after the rash appears (see the page Measles antibodies)
• Detection of viral RNA by RT-PCR on a throat or nasopharyngeal swab and on urine: allows early diagnosis, even in the first days of illness
• Genotyping of the virus detected by PCR: identifies the genotype and lineage, and therefore whether cases belong to the same transmission chain. It also distinguishes the vaccine strain from wild-type virus when a rash develops after vaccination, as PAHO itself recommends
• Measles IgG antibodies: indicate protection from vaccination or past infection and can be useful, for example, in healthcare workers or women planning a pregnancy, together with the rubella antibody test
What it means for us
The news concerns the Americas, but measles travels with people: every distant outbreak raises the risk of imported cases in Europe and Italy too. Measles is not a trivial illness: it can cause pneumonia, encephalitis, blindness and, in the most severe cases, death; it also weakens the immune system for months after recovery.
Anyone unsure whether they are protected can check their vaccination status with their family doctor, who will assess whether an antibody test or vaccination according to the immunisation schedule is appropriate (see the Vaccine dossier).
Who should take note
• Parents of young children, especially infants too young to be vaccinated, who are protected only if the people around them are
• Adults who are not sure whether they have had measles or two doses of vaccine
• Healthcare workers and travellers to the Americas
• Women planning a pregnancy
Limitations
• The 2026 data are provisional and may be updated in the coming weeks
• National figures are averages: PAHO stresses that they hide communities with much lower coverage, where the virus keeps circulating
• Case counts also depend on each country’s surveillance capacity, which is not uniform
• Losing the status is a public health indicator: on its own it does not describe the risk for an individual traveller
In summary
• The United States, Mexico and Bolivia have lost measles elimination status after more than 12 months of circulation of the same strain
• Cases in the Americas in 2026 are more than four times those of 2025, with 82 deaths
• Laboratory genotyping of the virus is the tool that made it possible to document continuous transmission
• According to PAHO, the way back to elimination is at least 95% coverage with two vaccine doses in every community
Sources:
PAHO, press release of 17 November 2026; Quotidiano Sanità; Reuters (via US News); Il Sole 24 Ore
Laboratory tests:
Anticorpi anti morbillo, Anticorpi anti rosolia (Rubeotest), Anticorpi anti parotite, Anticorpi anti varicella
Diseases, symptoms and related pages:
Morbillo, Dossier vaccini: obbligatori e facoltativi, Pediatria (malattie dei bambini), Polmonite bilaterale, Influenza 2026-2027: riparte RespiVirNet














































Discussion about this post